NTT DATA announces the acquisition of The Cloud People Group AS, one of the largest pure-play ServiceNow partners in Europe. Founded in ...

BIELEFELD, Germany and SÃO PAULO, Dec. 3, 2025 /PRNewswire/ -- NTT DATA Business Solutions, a leading global IT service provider focused on SAP, today announced the signing of an agreement to acquire ...

Good afternoon, and welcome to Spero Therapeutics Second Quarter 202 Earnings Conference Call. [Operator Instructions] Please be advised that this call is being recorded, and a replay will be ...

The phase 3 Pivot PO trial for tepipenem HBR in complicated urinary tract infections (CUTIs) met its primary endpoint and was stopped early for efficacy. Tepipenem HBR demonstrated non-inferiority to ...

We recently published a list of Small Stocks, But Explosive: These 10 Firms Crushed The Market Last Week. In this article, we are going to take a look at where Spero Therapeutics, Inc. (NASDAQ:SPRO) ...

Spero Therapeutics' tebipenem, an oral carbapenem for cUTIs, has high approval potential, supported by a successful phase 3 trial and a GSK licensing deal. The need for oral carbapenems is critical ...

Fintel reports that on December 20, 2024, Evercore ISI Group downgraded their outlook for Spero Therapeutics (NasdaqGS:SPRO) ...

A downtrend has been apparent in Spero Therapeutics, Inc. (SPRO) lately with too much selling pressure. The stock has declined 9.3% over the past four weeks. However, given the fact that it is now in ...